vs
Side-by-side financial comparison of EverQuote, Inc. (EVER) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $195.3M, roughly 1.1× EverQuote, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 29.6%, a 27.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $25.8M).
EverQuote, Inc. is an online insurance marketplace founded in 2011 and based in Cambridge, Massachusetts.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
EVER vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $195.3M | $207.8M |
| Net Profit | $57.8M | $119.2M |
| Gross Margin | 97.7% | — |
| Operating Margin | 9.5% | 52.2% |
| Net Margin | 29.6% | 57.4% |
| Revenue YoY | 32.5% | — |
| Net Profit YoY | 369.3% | 330.1% |
| EPS (diluted) | $1.53 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $195.3M | — | ||
| Q3 25 | $173.9M | $207.8M | ||
| Q2 25 | $156.6M | — | ||
| Q1 25 | $166.6M | — | ||
| Q4 24 | $147.5M | — | ||
| Q3 24 | $144.5M | $0 | ||
| Q2 24 | $117.1M | $0 | ||
| Q1 24 | $91.1M | $0 |
| Q4 25 | $57.8M | — | ||
| Q3 25 | $18.9M | $119.2M | ||
| Q2 25 | $14.7M | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $12.3M | — | ||
| Q3 24 | $11.6M | $-51.8M | ||
| Q2 24 | $6.4M | $-52.8M | ||
| Q1 24 | $1.9M | $-39.6M |
| Q4 25 | 97.7% | — | ||
| Q3 25 | 97.3% | — | ||
| Q2 25 | 96.9% | — | ||
| Q1 25 | 96.8% | — | ||
| Q4 24 | 96.3% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 95.7% | — | ||
| Q1 24 | 94.5% | — |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 10.1% | 52.2% | ||
| Q2 25 | 9.0% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | 29.6% | — | ||
| Q3 25 | 10.8% | 57.4% | ||
| Q2 25 | 9.4% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 8.0% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | $1.53 | — | ||
| Q3 25 | $0.50 | $1.33 | ||
| Q2 25 | $0.39 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $0.35 | — | ||
| Q3 24 | $0.31 | $-0.60 | ||
| Q2 24 | $0.17 | $-0.68 | ||
| Q1 24 | $0.05 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $171.4M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $238.0M | $1.1B |
| Total Assets | $326.9M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.4M | — | ||
| Q3 25 | $145.8M | $786.9M | ||
| Q2 25 | $148.2M | — | ||
| Q1 25 | $125.0M | — | ||
| Q4 24 | $102.1M | — | ||
| Q3 24 | $82.8M | $920.0M | ||
| Q2 24 | $60.9M | $701.7M | ||
| Q1 24 | $48.6M | $698.8M |
| Q4 25 | $238.0M | — | ||
| Q3 25 | $174.9M | $1.1B | ||
| Q2 25 | $170.3M | — | ||
| Q1 25 | $149.5M | — | ||
| Q4 24 | $135.4M | — | ||
| Q3 24 | $117.7M | $1.2B | ||
| Q2 24 | $100.8M | $931.7M | ||
| Q1 24 | $88.3M | $935.3M |
| Q4 25 | $326.9M | — | ||
| Q3 25 | $256.1M | $1.2B | ||
| Q2 25 | $241.4M | — | ||
| Q1 25 | $232.1M | — | ||
| Q4 24 | $210.5M | — | ||
| Q3 24 | $180.5M | $1.2B | ||
| Q2 24 | $158.0M | $973.7M | ||
| Q1 24 | $135.4M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.0M | $142.2M |
| Free Cash FlowOCF − Capex | $25.8M | $142.2M |
| FCF MarginFCF / Revenue | 13.2% | 68.4% |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.47× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $90.3M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.0M | — | ||
| Q3 25 | $19.8M | $142.2M | ||
| Q2 25 | $25.3M | — | ||
| Q1 25 | $23.3M | — | ||
| Q4 24 | $20.1M | — | ||
| Q3 24 | $23.6M | $-49.2M | ||
| Q2 24 | $12.4M | $-32.9M | ||
| Q1 24 | $10.4M | $-43.8M |
| Q4 25 | $25.8M | — | ||
| Q3 25 | $18.5M | $142.2M | ||
| Q2 25 | $23.8M | — | ||
| Q1 25 | $22.2M | — | ||
| Q4 24 | $19.1M | — | ||
| Q3 24 | $22.1M | $-49.7M | ||
| Q2 24 | $11.5M | $-33.9M | ||
| Q1 24 | $9.7M | $-45.1M |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 10.6% | 68.4% | ||
| Q2 25 | 15.2% | — | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | 10.6% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 0.47× | — | ||
| Q3 25 | 1.05× | 1.19× | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 2.92× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.93× | — | ||
| Q1 24 | 5.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVER
| Automotive | $179.9M | 92% |
| Home And Renters | $15.4M | 8% |
IDYA
Segment breakdown not available.
